Skip to main content
KBIO COMPANY Inc. logo

KBIO COMPANY Inc. — Investor Relations & Filings

Ticker · 038530 ISIN · KR7038530002 KO Manufacturing
Open in API
Filings indexed 440 across all filing types
Latest filing 2024-02-28 Earnings Release
Country KR South Korea
Listing KO 038530

About KBIO COMPANY Inc.

https://kbio.com/

KBio specializes in plant-based manufacturing of biologics. The company utilizes its proprietary RP3 platform, which leverages plants as biofoundries for the efficient and sustainable production of high-quality proteins, therapeutics, and other bioactive compounds. This innovative approach is designed to surpass traditional manufacturing limitations, enabling the rapid development and large-scale production of biomolecules. The company's focus includes developing novel product candidates such as antibody therapies to address public health challenges and areas of high unmet medical need.

Recent filings

Filing Released Lang Actions
[기재정정]매출액또는손익구조30%(대규모법인은15%)이상변동
Earnings Release Classification · 100% confidence The document is a regulatory filing from a Korean company (K-Bio) regarding a 'Correction Report' (정정신고) for a previous disclosure concerning a significant change (over 30%) in revenue or profit structure. It provides updated financial figures, specifically shifting from individual to consolidated financial statements. This type of disclosure is a standard regulatory requirement for material financial changes and does not constitute a full annual report, earnings release, or other specific category, making 'RNS' (Regulatory Filings) the most appropriate classification. FY 2023
2024-02-28 Korean
매출액또는손익구조30%(대규모법인은15%)이상변동
Earnings Release Classification · 100% confidence The document is a regulatory filing from a Korean company (K-Bio) announcing a significant change (over 30%) in revenue or profit structure. This type of disclosure is a standard regulatory requirement for listed companies to report material financial changes before the final audit is completed. It fits the definition of an Earnings Release (ER) as it provides key financial highlights and reasons for the variance in performance. FY 2023
2024-02-14 Korean
전환가액의조정
Capital/Financing Update Classification · 100% confidence The document is a formal regulatory filing from a South Korean company (K-Bio) regarding the 'Adjustment of Conversion Price' for convertible bonds. This type of filing is a standard disclosure in the Korean market (KRX) concerning capital structure changes and financial instruments. It does not fit into categories like Annual Reports, Earnings Releases, or M&A, but rather falls under the category of capital/financing updates as it directly impacts the conversion price and potential share dilution of existing debt instruments.
2024-01-24 Korean
전환가액의조정
Capital/Financing Update Classification · 100% confidence The document is a formal regulatory filing from a South Korean company (K-Bio) detailing the adjustment of the conversion price for convertible bonds (CB). This type of disclosure, which updates the terms of existing financial instruments due to market price fluctuations, is classified as a Capital/Financing Update (CAP) in our taxonomy, as it directly relates to the company's capital structure and debt-to-equity conversion terms.
2023-12-26 Korean
주주명부폐쇄기간또는기준일설정
Regulatory Filings Classification · 95% confidence The document is a short regulatory announcement regarding the setting of a record date for a shareholder meeting (closing of the shareholder register). It is a standard corporate governance notice, not a full report, and fits the criteria for a general regulatory filing or announcement regarding corporate actions.
2023-12-15 Korean
타법인주식및출자증권취득결정
M&A Activity Classification · 100% confidence The document is a regulatory filing from a Korean company (K-Bio) detailing the acquisition of shares in another company (Incon) through the exercise of convertible bond conversion rights. This type of disclosure is a standard corporate announcement regarding capital structure changes and investment activities, which falls under the 'Regulatory Filings' category as it does not fit into specific categories like M&A (which usually implies a takeover or merger) or Share Issue (which refers to the company's own shares).
2023-11-17 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.